News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Astellas Pharma US, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
The Day In Review: Novartis Corporation Pulls Zelnorm Off The Market
March 30, 2007
·
1 min read
Biotech Beach
The Day In Review: Crucell N.V. And Astellas Pharma Inc. Abandon Drugs
July 18, 2006
·
1 min read
Biotech Beach
The Day In Review: Biomira Inc. Cancer Drug Reports Positive Results
April 28, 2006
·
1 min read
Biotech Beach
The Day In Review: EpiCept Corporation Gains On Ceplene Success
March 31, 2006
·
1 min read
Business
Japanese Drugmakers Strengthen Area Ties
October 19, 2005
·
1 min read
Deals
Merger Mania Besets Japanese Pharmaceuticals
October 19, 2005
·
1 min read
Business
Astellas Pharma: Drugmaker To Add 75 New Jobs With State Aid
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients
May 12, 2026
·
9 min read
Press Releases
Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
April 30, 2026
·
9 min read
Press Releases
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
April 20, 2026
·
31 min read
Press Releases
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
April 17, 2026
·
6 min read
Press Releases
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
April 8, 2026
·
3 min read
Press Releases
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
February 24, 2026
·
10 min read
Press Releases
VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
January 9, 2026
·
15 min read
Press Releases
Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines
December 11, 2025
·
2 min read
Press Releases
PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
October 19, 2025
·
27 min read
Press Releases
Nikon Instruments and Astellas announce a strategic collaboration to offer SakuLab-Cambridge MA resident companies access to advanced imaging capabilities provided by Nikon BioImaging Lab USA
June 17, 2025
·
2 min read
